Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Burkitt lymphoma/leukemia: improving prognosis.
Expanding newborn screening for lysosomal disorders: opportunities and challenges.
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer.
Tacrolimus rescue therapy for renal transplant rejection.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tacrolimus rescue therapy for renal transplant rejection.
Tacrolimus rescue therapy for renal transplant rejection. Transplant Proc. 1996 Aug; 28(4):2119-20.
View in:
PubMed
subject areas
Adult
Antilymphocyte Serum
Cyclosporine
Drug Therapy, Combination
Female
Follow-Up Studies
Graft Rejection
Humans
Immunosuppressive Agents
Kidney Transplantation
Male
Prednisone
Reoperation
Salvage Therapy
Tacrolimus
authors with profiles
John Fung